Skip to main navigation
Skip to search
Skip to main content
Sort by
INIS
drugs
100%
cancer
62%
rats
58%
antioxidants
51%
fibrosis
48%
diseases
40%
in vitro
38%
therapy
36%
inflammation
36%
proteins
35%
nanoparticles
33%
inhibition
31%
kinases
30%
nanostructures
30%
receptors
29%
interactions
29%
pharmacology
27%
simulation
26%
lipids
26%
molecular dynamics method
25%
comparative evaluations
24%
delivery
24%
reviews
23%
lung cells
22%
design
22%
applications
21%
evaluation
21%
synthesis
21%
in vivo
20%
breasts
19%
enzymes
19%
molecules
18%
flavonoids
18%
liver
18%
oxidation
16%
growth factors
16%
screening
15%
coronaviruses
15%
modulation
14%
validation
14%
toxicity
14%
silica
14%
flavones
13%
lungs
13%
brain
13%
carriers
13%
biological availability
13%
ligands
13%
nervous system diseases
13%
humans
13%
Pharmacology, Toxicology and Pharmaceutical Science
Antioxidant
30%
Resveratrol
27%
SARS Coronavirus
23%
Inflammation
20%
Malignant Neoplasm
19%
Breast Cancer
19%
Drug Repositioning
17%
Antidiabetic Agent
17%
Network Pharmacology
17%
IC50
16%
Flavonoid
16%
Pharmacokinetics
16%
Fibrosing Alveolitis
15%
Disease
15%
Antioxidant Capacity
15%
Non Small Cell Lung Cancer
14%
Lung Fibrosis
14%
Bioavailability
13%
Nanoparticle
13%
Antibacterial Activity
13%
Receptor
12%
Nintedanib
12%
Petroleum Ether
11%
Proteinase
11%
Fenugreek
10%
Mesoporous Silica Nanoparticle
10%
Coronavirinae
9%
Antivirus Agent
8%
Quercetin
8%
Alzheimer's Disease
8%
Coumarin Derivative
8%
Drug Discovery
8%
Tumor Necrosis Factor
8%
Chitosan
8%
Wistar Rat
7%
Polyphenol
7%
Clinical Trial
7%
Preclinical Study
7%
Streptozotocin
6%
Glucuronic Acid
6%
Receptor Antagonist
6%
Ritonavir
6%
Receptor Agonist
6%
RNA Directed RNA Polymerase
6%
Antimicrobial Agent
6%
3 Hydroxyflavone
6%
Glycogen Synthase Kinase 3
6%
Mouth Disease
6%
Epigallocatechin Gallate
6%
Zeta Potential
6%